drugset / Trial / NCT01168505
Iron Supplement in the Prevention of Anemia in Female Breast Cancer Patients
Phase 2
Unknown
100 enrolled
Cancer Institute of the State of São Paulo
Fundação Faculdade de Medicina · collab
RandomizedParallel-groupOpen-labelPrevention
Summary
Study to evaluate the efficacy of intravenous iron supplementation in the prevention of anemia in patients receiving (neo)adjuvant breast cancer regimens.
Timeline
- Start
- 2010-05
- Primary completion
- 2014-12
- Completion
- 2014-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | ferric hydroxide saccharate | Unknown | 200 mg | Intravenous |